tiprankstipranks
Trending News
More News >
Ligand Pharma (LGND)
NASDAQ:LGND
Advertisement

Ligand Pharma (LGND) Similar Stocks

Compare
823 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Ligand Pharma
$202.48
$3.73B
66.99%
6 Buy
0 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$19.26
$2.49B
64.87
-33.19%
9 Buy
6 Hold
1 Sell
Moderate Buy
Scholar Rock Holding
$28.95
$2.77B
-0.45%
11 Buy
0 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$40.00
$4.01B
-34.09%
14 Buy
1 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$61.00
$4.39B
17.65%
20 Buy
0 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$10.63
$678.05M
-79.02%
9 Buy
5 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
LGND
Ligand Pharma
202.48
81.23
66.99%
APLS
Apellis Pharmaceuticals
19.26
-10.72
-35.76%
SRRK
Scholar Rock Holding
28.95
-0.13
-0.45%
CRNX
Crinetics Pharmaceuticals
40.00
-20.69
-34.09%
KYMR
Kymera Therapeutics
58.66
7.71
15.13%
MLTX
MoonLake Immunotherapeutics
10.63
-41.15
-79.47%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis